RemeGen’s Disitamab vedotin gains approval in China for its third indication making it the first...

U.S. FDA Approves EMRELIS (Telisotuzumab vedotin-tllv) for adults with previously treated advanced Non-Small Cell Lung...

ADC Therapeutics announces presentation of LOTIS-7 clinical trial data at the European Hematology Association 2025...

Minghui Pharmaceutical announces strategic partnership and licensing agreement with Qilu Pharmaceutical to develop B7-H3 ADC...

SparX Biopharmaceutical announces research agreement with Mitsubishi Tanabe Pharma America to advance novel antibody-drug conjugates

LigaChem Biosciences partners with Y Biologics for antibody technology